Physician profile
Walter A Thomas
NPI 1063404606
$11,753.34
in general payments reported to CMS, 2019-2025
10 companies · $22.30 in 2025
The $22.30 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,807 · 2020: $2,903 · 2021: $2,290 · 2022: $14.58 · 2023: $1,717 · 2025: $22.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,223 · Travel and Lodging: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.08 |
| Travel and Lodging | $515.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $9,075.86 | 2019-2023 | |
| Micromed INC | $1,355.85 | 2021 | |
| Smith+Nephew, INC. | $644.17 | 2019-2021 | |
| Goode Surgical INC | $249.02 | 2023 | |
| Saxum Surgical, INC. | $208.12 | 2023 | |
| Linvatec Corporation | $124.87 | 2023 | Biobrace 23mm, Linvatec Arthroscopy |
| Globus Medical, INC. | $31.90 | 2023 | Allocate |
| Sight Sciences, INC. | $26.67 | 2019 | |
| Abbott Laboratories | $22.30 | 2025 | Proclaim |
| Boston Scientific Corporation | $14.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.